CGAS and non-alcoholic fatty liver: Elevated levels of cGAS-STING signaling components, including cGAS, STING, and IRF3, have been observed in both human NAFL and NASH patients, as well as in high-fat diet (HFD) or NASH mouse models (9, 114).